Dr. Chalasani is the director of the hematology-oncology division at the George Washington Cancer Center (GWCC) and co-program lead for the Clinical Translational Oncology Program. After receiving her medical degree from Gandhi Medical College in India, she completed internship, residency and a fellowship in hematology-oncology at the University of Arizona, Tucson. She joined the University of Arizona Cancer Center (UACC) as a faculty member and served as program director for the hematology-oncology fellowship program. Dr. Chalasani is the principal investigator for several clinical trials and was awarded the prestigious NCI Clinical Cancer Investigator Team Leadership Award in 2020. She has received research funding from NIH/NCI, American Cancer Society, Better Than Ever and DOD.
Justina Frimpong, PharmD, BCOP is a Clinical Assistant Professor within the Department of Pharmacy Practice at Temple University School of Pharmacy (TUSP). Her clinical practice site resides in the outpatient setting with Medical Oncology at Fox Chase Cancer Center located at Temple University Hospital in North Philadelphia.
Dr. Frimpong holds active roles in local, state, and national pharmacy organizations. Her clinical and research areas of interest include oral antineoplastic therapy education, toxicity management/related supportive care, in addition to drug-drug and drug-disease interactions with oral antineoplastic agents.
Tammy Smith is a family nurse practitioner. She works at Virginia Cancer Specialists where she specializes in both medical and surgical oncology for the treatment of cancer. She is an Advanced Oncology Certified Nurse Practitioner and a certified breast care nurse.
Funding and support provided by Lilly Oncology. VV-OTHR-US-DEL-0992 © Lilly USA, LLC 2022. All rights reserved.
